Physician profile
Brett Blaser
NPI 1538471313
$12,381.32
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,445 · 2020: $2,379 · 2021: $5,503 · 2022: $3,036 · 2023: $19.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,546.95 | 2019-2022 | |
| Shire North American Group INC | $173.20 | 2019 | |
| Astellas Pharma US INC | $157.93 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $68.65 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $62.74 | 2019 | |
| Antares Pharma, INC. | $55.43 | 2019-2020 | |
| Abbvie INC. | $54.11 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.98 | 2019 | |
| Alkermes, INC. | $26.49 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.49 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.92 | 2019 | |
| Amgen INC. | $19.82 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $19.08 | 2023 | Rexulti |
| Pfizer INC. | $16.57 | 2019 | |
| Strongbridge US INC. | $14.68 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $13.94 | 2019 | |
| Allergan, INC. | $13.56 | 2019 | |
| Biogen, INC. | $13.23 | 2019 | |
| Genentech USA, INC. | $12.69 | 2019 | |
| Novo Nordisk INC | $11.76 | 2019 | |
| Amarin Pharma, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Blaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.